Tags: Chemical Compound, Chemical Substance.

Lonafarnib is a farnesyltransferase inhibitor (FTI) that is being investigated in a human clinical trial as a potential treatment for progeria.Lonafarnib is a synthetic tricyclic derivative of carboxamide with antineoplastic properties. As such it is used primarily for cancer treatment. For those with progeria research has shown that the drug reduces the prevalence of stroke and transient ischemic attack and the prevalence and frequency of headaches while taking the medication.

Lonafarnib.png
FDA UNII code
IOW153004F
IUPAC name
(4-(2-(4-(8-Chloro-310-dibromo-611-dihydro-5H-benzo(56)cyclohepta(12-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxamide)

Loading...

This page contains content from the copyrighted Wikipedia article "Lonafarnib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.